ASTAGRAF XL is a Oral Capsule, Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Tacrolimus.
| Product ID | 0469-0647_4b0d99f4-01fe-47b4-a447-70c996917f4a | 
| NDC | 0469-0647 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | ASTAGRAF XL | 
| Generic Name | Tacrolimus Extended-release Capsules | 
| Dosage Form | Capsule, Coated, Extended Release | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2013-07-19 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA204096 | 
| Labeler Name | Astellas Pharma US, Inc. | 
| Substance Name | TACROLIMUS | 
| Active Ingredient Strength | 1 mg/1 | 
| Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2013-07-19 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA204096 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2013-07-19 | 
| Marketing Category | NDA | 
| Application Number | NDA204096 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2013-07-19 | 
| Marketing End Date | 2019-06-24 | 
| Ingredient | Strength | 
|---|---|
| TACROLIMUS | .5 mg/1 | 
| SPL SET ID: | 550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0469-0647 | ASTAGRAF XL | tacrolimus extended-release capsules | 
| 0469-0677 | ASTAGRAF XL | tacrolimus extended-release capsules | 
| 0469-0687 | ASTAGRAF XL | tacrolimus extended-release capsules | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  ASTAGRAF XL  85925271  4480263 Live/Registered | Astellas Pharma Inc. 2013-05-07 |